Duke Cancer Institute
Patient Care
Research Programs
  • Home
  • Programs and Groups
  • Shared Resources
  • Faculty
  • Clinical Trials
    • Clinical Trials FAQs
  • Tumor Registry
  • Education
  • About DCI

Quick Links

  • Patient Care
  • Giving to DCI
  • Contact Us

Breadcrumbs Navigation

Home > Clinical Trials > Pediatric Clinical Trials - Pediatric Rare Tumor
Jumbo Large Regular Text:
Print
Clinical Trials

Pediatric Clinical Trials - Pediatric Rare Tumor

If you would like to inquire about all open trials, please contact 919-684-3401.

Items 1 - 5 of 5
ANHL1131 Intergroup Trial for Children or Adolescents with B-cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
Principal Investigator: Susan Kreissman
Phase: Phase II
Phone: 919-684-3401
AHEP0731 Treatment of Children with All Stages of Hepatoblastoma
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
ARAR0331 Treatment of Childhood Nasopharyngeal Carcinoma with Neoadjuvant Chemotherapy and Concomitant Chemoradioatherapy
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
ARAR0332 Treatment of Adrenocortical Tumors with Surgery plus Lymph Node Dissection and Multiagent Chemotherapy
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
ARET0321 A Trial of Intensive Multi-Modality Therapy for Extra-Ocular Retinoblastoma
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
Facebook
Twitter
YouTube
Contact Us | Careers | Make a Gift | Site Map
Duke Medicine | Duke School of Medicine | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System